We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-6.42%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.49B
AUM Growth
-$229M
Cap. Flow
-$115M
Cap. Flow %
-7.69%
Top 10 Hldgs %
22.33%
Holding
2,451
New
741
Increased
498
Reduced
386
Closed
708

Top Sells

Rank Stock Value
1
AET
Aetna Inc
AET
+$48.3M
2
COL
Rockwell Collins
COL
+$34.6M
3
DELL icon
Dell
DELL
+$33.7M
4
CA
CA, Inc.
CA
+$33.7M
5
NXPI icon
NXP Semiconductors
NXPI
+$23.7M

Sector Composition

Rank Sector Weight
1 Technology 11.52%
2 Communication Services 10.15%
3 Healthcare 7.28%
4 Consumer Discretionary 5.72%
5 Financials 4.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRTX
301
TPG RE Finance Trust
TRTX
$618M
$1.01M 0.07%
+55,437
New +$1.09M
ABBV icon
302
AbbVie
ABBV
$435B
$1.01M 0.07%
+10,956
New +$963K
FE icon
303
FirstEnergy
FE
$27.5B
$991K 0.07%
26,379
+21,792
+475% +$826K
PODD icon
304
Insulet
PODD
$9.79B
$989K 0.07%
12,466
+2,028
+19% +$172K
TTWO icon
305
Take-Two Interactive
TTWO
$46.1B
$989K 0.07%
9,607
-9,456
-50% -$1.09M
CRM icon
306
PUT
Salesforce
CRM
$158B
$986K 0.07%
+7,200
New +$990K
FMHI icon
307
First Trust Municipal High Income ETF
FMHI
$1B
$983K 0.07%
+19,660
New +$979K
PARA
308
DELISTED
Paramount Global Class B
PARA
$975K 0.07%
22,301
-145,325
-87% -$7.72M
JPM icon
309
JPMorgan Chase
JPM
$950B
$973K 0.07%
9,967
-24,158
-71% -$2.57M
TMO icon
310
Thermo Fisher Scientific
TMO
$220B
$964K 0.06%
+4,307
New +$1.01M
EBAY icon
311
CALL
eBay
EBAY
$49.8B
$957K 0.06%
34,100
AMBA icon
312
Ambarella
AMBA
$3.81B
$955K 0.06%
27,312
+22,455
+462% +$795K
MPT
313
Medical Properties Trust
MPT
$2.81B
$954K 0.06%
59,320
+12,730
+27% +$201K
GM icon
314
General Motors
GM
$76.8B
$948K 0.06%
28,354
-34,850
-55% -$1.2M
NTNX icon
315
Nutanix
NTNX
$16.9B
$947K 0.06%
22,777
+13,067
+135% +$540K
GE icon
316
PUT
GE Aerospace
GE
$384B
$942K 0.06%
25,978
+24,809
+2,122% +$1.12M
BKR icon
317
Baker Hughes
BKR
$61.1B
$940K 0.06%
43,739
+40,825
+1,401% +$1.04M
NWL icon
318
PUT
Newell Brands
NWL
$2.56B
$926K 0.06%
49,800
+49,500
+16,500% +$984K
CDLX icon
319
Cardlytics
CDLX
$21.5M
$920K 0.06%
+8,492
New +$1.43M
TKR icon
320
Timken Company
TKR
$9.03B
$913K 0.06%
24,468
+8,050
+49% +$326K
CLX icon
321
Clorox
CLX
$12.7B
$908K 0.06%
+5,889
New +$917K
BBWI icon
322
Bath & Body Works
BBWI
$4.1B
$907K 0.06%
43,692
+27,476
+169% +$692K
VMW
323
CALL
DELISTED
VMware, Inc
VMW
$905K 0.06%
6,600
-1,300
-16% -$196K
EPRT icon
324
Essential Properties Realty Trust
EPRT
$6.62B
$896K 0.06%
64,762
-27,852
-30% -$387K
INDP icon
325
Indaptus Therapeutics
INDP
$157M
$890K 0.06%
+53
New +$723K

Similar funds

Prelude Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Prelude Capital Management held 2,451 positions worth $1.49B, down 13% from $1.72B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Prelude Capital Management withdrew a net $115M in Q4 2018, closing 708 positions and reducing 386 holdings. Its most notable exit was Aetna Inc, an estimated $48.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 15% a quarter earlier, followed by Communication Services and Healthcare.

Against the trend, Prelude Capital Management opened a new position in Red Hat Inc worth $33.2M.

  • Prelude Capital Management's largest Q4 2018 buy was Red Hat Inc: 189,248 shares worth $33.2M.
  • Prelude Capital Management added most to Athenahealth, Inc. in Q4 2018, an estimated $16M increase.
  • Prelude Capital Management's biggest Q4 2018 reduction was Dell, cutting an estimated $33.7M.
  • Prelude Capital Management fully exited Aetna Inc in Q4 2018, selling an estimated $48.3M.
  • Prelude Capital Management's ten largest holdings make up 22% of its $1.49B portfolio in Q4 2018.
  • Prelude Capital Management opened 741 new positions and closed 708 in Q4 2018.
  • Prelude Capital Management's portfolio value fell 13% quarter-over-quarter to $1.49B.

Based on Prelude Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.